176 related articles for article (PubMed ID: 18413661)
1. Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression.
Ferri N; Granata A; Pirola C; Torti F; Pfister PJ; Dorent R; Corsini A
Mol Pharmacol; 2008 Jul; 74(1):144-53. PubMed ID: 18413661
[TBL] [Abstract][Full Text] [Related]
2. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
Fouty BW; Rodman DM
Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.
Zhu S; Viswambharan H; Gajanayake T; Ming XF; Yang Z
BMC Cardiovasc Disord; 2005 Jul; 5():22. PubMed ID: 16018822
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
5. Onychin inhibits proliferation of vascular smooth muscle cells by regulating cell cycle.
Yang M; Huang HL; Zhu BY; Tuo QH; Liao DF
Acta Pharmacol Sin; 2005 Feb; 26(2):205-11. PubMed ID: 15663900
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells.
Havrda MC; Johnson MJ; O'Neill CF; Liaw L
Thromb Haemost; 2006 Sep; 96(3):361-70. PubMed ID: 16953280
[TBL] [Abstract][Full Text] [Related]
8. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
10. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.
Yazbeck VY; Buglio D; Georgakis GV; Li Y; Iwado E; Romaguera JE; Kondo S; Younes A
Exp Hematol; 2008 Apr; 36(4):443-50. PubMed ID: 18343280
[TBL] [Abstract][Full Text] [Related]
11. Antirestenotic mechanisms of everolimus on human coronary artery smooth muscle cells: inhibition of human coronary artery smooth muscle cell proliferation, but not migration.
Lavigne MC; Grimsby JL; Eppihimer MJ
J Cardiovasc Pharmacol; 2012 Feb; 59(2):165-74. PubMed ID: 21983747
[TBL] [Abstract][Full Text] [Related]
12. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I
Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling.
Kim TJ; Han HJ; Lim Y; Song MC; Kim J; Hong JT; Yoo HS; Pyo MY; Hwang BY; Lee MK; Yun YP
J Cardiovasc Pharmacol; 2009 Apr; 53(4):341-8. PubMed ID: 19295442
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
15. [Effect of shikonin, a phytocompound from Lithospermum erythrorhizon, on rat vascular smooth muscle cells proliferation and apoptosis in vitro].
Zhang ZQ; Cao XC; Zhang L; Zhu WL
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1484-8. PubMed ID: 16061028
[TBL] [Abstract][Full Text] [Related]
16. Humic acid induces G1 phase arrest and apoptosis in cultured vascular smooth muscle cells.
Hseu YC; Lin E; Chen JY; Liua YR; Huang CY; Lu FJ; Liao JW; Chen SC; Yang HL
Environ Toxicol; 2009 Jun; 24(3):243-58. PubMed ID: 18683188
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
18. [Effect of weikangning decoction on expression of cyclin E, CDK2, and p27].
Kan FJ; Li QM; Zhong W; Liang WW
Zhong Yao Cai; 2006 Apr; 29(4):341-5. PubMed ID: 16913488
[TBL] [Abstract][Full Text] [Related]
19. STAT1 requirement for PKR-induced cell cycle arrest in vascular smooth muscle cells in response to heparin.
Handy I; Patel RC
Gene; 2013 Jul; 524(1):15-21. PubMed ID: 23597922
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]